Home LiteratureArticle Details
PMID: 28594889 Published · epublish English Journal Article

Use of the FDA nozzle model to illustrate validation techniques in computational fluid dynamics (CFD) simulations.

PloS one ·Vol. 12 ·No. 6 ·2017-00-00 ·页码 e0178749

Hariharan P, D'Souza GA, Horner M, Morrison TM, Malinauskas RA, Myers MR

Abstract

A "credible" computational fluid dynamics (CFD) model has the potential to provide a meaningful evaluation of safety in medical devices. One major challenge in establishing "model credibility" is to determine the required degree of similarity between the model and experimental results for the model to be considered sufficiently validated. This study proposes a "threshold-based" validation approach that provides a well-defined acceptance criteria, which is a function of how close the simulation and experimental results are to the safety threshold, for establishing the model validity. The validation criteria developed following the threshold approach is not only a function of Comparison Error, E (which is the difference between experiments and simulations) but also takes in to account the risk to patient safety because of E. The method is applicable for scenarios in which a safety threshold can be clearly defined (e.g., the viscous shear-stress threshold for hemolysis in blood contacting devices). The applicability of the new validation approach was tested on the FDA nozzle geometry. The context of use (COU) was to evaluate if the instantaneous viscous shear stress in the nozzle geometry at Reynolds numbers (Re) of 3500 and 6500 was below the commonly accepted threshold for hemolysis. The CFD results ("S") of velocity and viscous shear stress were compared with inter-laboratory experimental measurements ("D"). The uncertainties in the CFD and experimental results due to input parameter uncertainties were quantified following the ASME V&V 20 standard. The CFD models for both Re = 3500 and 6500 could not be sufficiently validated by performing a direct comparison between CFD and experimental results using the Student's t-test. However, following the threshold-based approach, a Student's t-test comparing |S-D| and |Threshold-S| showed that relative to the threshold, the CFD and experimental datasets for Re = 3500 were statistically similar and the model could be considered sufficiently validated for the COU. However, for Re = 6500, at certain locations where the shear stress is close the hemolysis threshold, the CFD model could not be considered sufficiently validated for the COU. Our analysis showed that the model could be sufficiently validated either by reducing the uncertainties in experiments, simulations, and the threshold or by increasing the sample size for the experiments and simulations. The threshold approach can be applied to all types of computational models and provides an objective way of determining model credibility and for evaluating medical devices.

MeSH 主题词
Computer Simulation Hydrodynamics Models, Theoretical
作者与单位
共 6 位作者,点击展开单位 / ORCID
Hariharan Prasanna
US Food and Drug Administration, Silver Spring, Maryland, United States of America.
D'Souza Gavin A
US Food and Drug Administration, Silver Spring, Maryland, United States of America.
Horner Marc
ANSYS, Inc., Evanston, Illinois, United States of America.
Morrison Tina M
US Food and Drug Administration, Silver Spring, Maryland, United States of America.
Malinauskas Richard A
US Food and Drug Administration, Silver Spring, Maryland, United States of America.
Myers Matthew R
US Food and Drug Administration, Silver Spring, Maryland, United States of America.
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2017-00-00
电子出版
2017-00-08
页码
e0178749
Language
English
Country/Region
United States
NLM ID
101285081
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]